|
S.A. Davlatbiev, Sh.P. Abdullaev, Sh.Yu. Dalgatov, M.N. Shatokhin, G.G. Borisenko, O.V. Teodorovich
Specific features of surgical treatment of urolithiasis in overweight patients
|
№5 / 2023
|
|
N.A. Nashivochnikova, V.N. Krupin, V.E. Leanovich
The role of antioxidants in the therapy of metabolic syndrome in men
|
№4 / 2023
|
|
V.V. Protoshchak, M.V. Paronnikov, P.A. Babkin, A.V. Sleptsov
Prevention of urolithiasis using febuxostat in patients with metabolic syndrome
|
№3 / 2023
|
|
O.I. Bratchikov, I.A. Tyuzikov, S.O. Artishchev, E.A. Shumakova
The role of obesity in the pathogenesis of benign prostatic hyperplasia
|
№2 / 2020
|
|
I.A. Korneyev, T.A. Alexeeva, M.K. Potapova, N.M. Alexeeva, S.Kh. Al-Shukri
Lower urinary tract symptoms in young adult men: analysis of prevalence, profile and relationship with metabolic syndrome’ risk factors
|
№1 / 2019
|
|
O.I. Bratchikov, S.O. Artishchev, I.A. Tyuzikov
Vitamin D deficiency, metabolic syndrome, and prostate adenoma: current epidemiological trends and pathophysiological mechanisms of interaction
|
№4 / 2018
|
|
A.V. Osadchii, E.V. Kulchavenya
Metabolic syndrome as a cause of reduced ejaculate fertility in patients with prostatic tuberculosis
|
№4 / 2016
|
|
I.A. Korneev, T.A. Alekseeva, M.I. Kogan, D.Yu. Pushkar'
Epidemiology of urinary disorders in men in the Russian Federation
|
№2 (supplement) / 2016
|
|
I.A. Tyuzikov, E.A. Grekov, S.Yu. Kalinchenko
Features of Clinical Course and Morphometric Parameters of Benign Prostatic Hyperplasia in Men with Metabolic Syndrome and Androgen Deficiency
|
№5 / 2015
|
|
I.A. Korneev, T.A. Alekseeva, S.Kh. Al-Shukri, A.N. Bernikov, A.A.Erkovich, V.N. Zhuravlev, A.A. Kamalov, M.I. Kogan, V.N. Pavlov, D.Yu. Pushkar
Determinants of risk of the development of erectile dysfunction in the Russian Federation: analysis of epidemiological studies
|
№3 / 2014
|
|
Pavlov V.N., Alekseyev A.V., Agaverdiyev A.F., Ishemgulov R.R.
Water and electrolyte metabolism disturbances in patients with metabolic syndrome
|
№4 / 2012
|
Русский
